CureBay raises $21 million in Series B round

(From left) Shobhan Mahapatra, Co-Founder, CureBay, Priyadarshi Mohapatra, Founder & CEO, CureBay, Sanjay Swain, Co-Founder, CTO, CureBay
| Photo Credit:
Special arrangement

Healthtech company CureBay has raised $21 million in its Series B funding round led by Bertelsmann India Investments. The round saw participation from existing investor Elevar Equity, British International Investment.

The latest capital infusion will be utlised to strengthen CureBay’s in-house, proprietary technology stack, expansion across India, and hiring. Further, the company aims to expand its footprint to new states, including Jharkhand, Bihar, Uttar Pradesh and Madhya Pradesh. It will also invest in platform upgrades, proprietary algorithms and rural-first workflow automation tools that can one day be adapted for global health contexts. 

Commenting on the development, Priyadarshi Mohapatra, Founder and CEO of CureBay, said, “The capital will help us scale technology, talent, and reach to bring dignified, affordable healthcare to the last mile.”

Pankaj Makkar, Managing Director, Bertelsmann India Investments, said, “While most rural solutions remain fragmented, CureBay uniquely delivers the full continuum of care under one platform, integrating consultations, diagnostics, pharmacy access, and surgeries through its tech-enabled eClinics.”

Launched in 2021 and headquartered in Odisha, CureBay has developed a scalable eClinic network. It provides quality, accessible and affordable services for doctor consultation, diagnostics, pharmacy and tertiary care for rural households and has a network of over 150 eClinics operational across Odisha and Chhattisgarh.

Published on May 20, 2025